Quantitative data analysis shows that rhEPO treatment substantially increased the percentage of CNPase cells reactive to BrdU (12.5±2.1%, n = 5) compared with the rats treated with saline (5.3±1.6%, n = 7) 28 days after stroke, suggesting that EPO enhances generation of new myelinating oligodendrocytes. Here, EPO is linked to stroke disorder.